Delphinol® positively affects blood glucose and fat levels. In addition to clinical studies on acute glucose tolerance and insulin levels performed in 2014 showing effect on SGLT (patented), further positive effects on blood parameters were observed in a new clinical study on pre-diabetic subjects. Intake of Delphinol® lowered HbA 1c levels over a period of three months and mean HDL to LDL cholesterol levels were significantly improved from 0.3 to 0.4.
Further studies to understand the full positive effects of Delphinol® are underway. Safety investigations have confirmed absence of health risks related to regular consumption of Delphinol®. In the USA Delphinol® has been affirmed as Generally Recognized As Safe (GRAS).
